Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Johnson & Johnson stock declined 2.22% on September 8, 2026, underperforming the S&P 500's 0.58% loss. The company is expected to report earnings on October 13, 2026, with forecasted EPS of $2.95 (up 5.36% YoY) and revenue of $25.36 billion (up 5.71% YoY). JNJ holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 23.75, trading at a premium to its industry average.